RxDoctor Payments Data

Joseph Santi, DPM

Foot & Ankle Surgery · Brooklyn, NYNPI 1497051254

Payments from drug & device makers

$5,553in general payments, 2019–2025

Across 123 payments — averaging $45.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$1K
  • Stryker$625
  • Bioventus LLC$575
  • Smith+Nephew$437
  • Abbott$391
  • Paratek Pharmaceuticals, Inc.$363
  • plus $2K from 26 others

What the payments were for

  • Consulting fees$1242%
  • Speaking & faculty fees$331%
  • Food & beverage$5,36297%
  • Gifts$351%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,553 in reported general payments places this provider in the 70th percentile of 652 foot & ankle surgery providers in New York.

See all foot & ankle surgery providers in New York

Medicare billing

Part B allowed, 2024
$234,839
Medicare patients
148
Services billed
962

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxepin Hcl18$2,314
Clotrimazole48$1,952
Fluocinonide18$1,383
Diclofenac Sodium ErDiclofenac Sodium16$1,139
Gentamicin Sulfate23$1,116
Ketoconazole27$832
Ammonium Lactate48$574
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip23$568
Diclofenac Sodium22$327
Mupirocin42$302
Doxycycline Hyclate26$164
Meloxicam13$23

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →